DOI:
10.1055/s-00000017
Experimental and Clinical Endocrinology & Diabetes
LinksClose Window
References
Nilsson AG, Bergthorsdottir R, Burman P. et al.
Long-term safety of once-daily, dual-release hydrocortisone in patients with adrenal insufficiency: A phase 3b, open-label, extension study.
Eur J Endocrinol 2017;
176: 715-725
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.